Showing results (161-170 of 190) with videos related to
Sort By:
Pageof 19
Haematologica|April 2, 2026
First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignanciesUri Ilan, Judith M Boer, Maaike Luesink, et al.Leukemia|December 30, 2022
High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemiaZakia Aid, Elie Robert, Cécile K Lopez, et al.Neuro-Oncology Advances|July 16, 2020
Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade gliomaStephanie Vairy, Gwénaël Le Teuff, Francisco Bautista, et al.Journal for Immunotherapy of Cancer|September 2, 2022
Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastomaAna Costa, Cécile Thirant, Amira Kramdi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal TumorsLeo Mascarenhas, Steven G DuBois, Catherine M Albert, et al.Expert Opinion on Drug Discovery|June 13, 2017
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma projectLucas Moreno, Hubert Caron, Birgit Geoerger, et al.Cancer Discovery|March 16, 2022
The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent MalignanciesPablo Berlanga, Gaelle Pierron, Ludovic Lacroix, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell LeukemiaAnouchka P Laurent, Aurélie Siret, Cathy Ignacimouttou, et al.Nature Communications|May 4, 2023
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastomaCécile Thirant, Agathe Peltier, Simon Durand, et al.Nature Genetics|July 26, 2017
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitriesValentina Boeva, Caroline Louis-Brennetot, Agathe Peltier, et al.Pageof 19